Nav: Home

Preeminent experts provide roadmap for future melanoma research

April 18, 2016

Recently the Melanoma Research Foundation (MRF) convened a summit of internationally-renowned melanoma experts for an in-depth discussion on the current understanding of, and future recommendations for, melanoma research. The result of the comprehensive process is a new white paper entitled, "The State of Melanoma: Challenges and Opportunities," published in the latest edition of the premier melanoma journal, Pigment Cell & Melanoma Research. In the white paper, the melanoma experts, including researchers, clinicians and patient advocates, identify the critical issues related to prevention, detection and early diagnosis, dormancy, metastasis and therapy.

"The MRF brought together these experts to develop recommendations that will drive the future of melanoma research and make major strides toward our goal of eradicating this deadly and elusive cancer once and for all," said Tim Turnham, Ph.D., executive director of the MRF. "Throughout the past ten years progress has been made in understanding melanoma, but the work is not done. Still, almost half of people with melanoma are without effective treatment options. This collaborative process and the resulting roadmap will help us get there."

In 2016 an estimated 144,000 people will be diagnosed with melanoma, resulting in nearly 10,000 deaths. Ten new therapeutic regimens were approved from 2011 to 2015 giving hope to patients and families. Despite the advances in these new treatments much is unknown including how to sequence and/or combine available treatments, what allows some tumors to build up resistance to therapy, and which drug is likely to work best with which patient.

"The MRF, together with the melanoma scientific and research communities, is unnerved that melanoma continues to effect hundreds of thousands of people every year. Because of this, we felt it absolutely necessary to spearhead this discussion among leading melanoma researchers," continued Turnham. "To decrease the incidence and mortality of melanoma, a number of critical questions must be answered. We're pleased this white paper does just that."

The white paper includes a roadmap that outlines the challenges and opportunities across the melanoma landscape. Key takeaways include:
  • Proper use of sunscreen can reduce incidence of melanoma by up to 50%. Current sunscreens block portions of both UVA and UVB, but not everything within those bands. More research needs to be done about what range of wavelengths in the UV band needs to be blocked.
  • Melanoma cells have demonstrated the ability to remain dormant in the body for many years--even decades. Understanding how these cells can survive and what causes them to awaken and progress is a vital component to melanoma treatment.
  • Currently 25 biopsies are performed for every melanoma found. Given the incidence of melanoma, and a demonstrated 40-70% underreporting rate, this translates to more than 4 million biopsies performed to diagnose 170,000 melanomas. Developing more precise methods of diagnosis will reduce anxiety for patients and significantly benefit healthcare costs.
  • Clinicians are seeing resistance to immunotherapy develop after an initial positive response. Identifying how acquired resistance happens--whether with targeted therapy or immunotherapy--and how to overcome resistance is essential in maximizing the benefit of these treatments.

"Melanoma has several unique characteristics, which pose challenges for its prevention and treatment" said Ze'ev A. Ronai, Ph.D. Professor and Chief Scientific Advisor, Sanford Burnham Perbys Medical Discovery Institute, and Co-Chair of the MRF's Scientific Advisory Committee. "Continued research is key to understanding the mechanisms behind the disease's development and growth, and is necessary to advance the treatment of - and potential cure for - melanoma. This document will help researchers, funders and advocates determine how their approach to melanoma fits within the current landscape and future needs."
To access an executive summary of the white paper, "The State of Melanoma: Challenges and Opportunities," click here.


Related Melanoma Articles:

Immunity against melanoma is only skin deep
Researchers at Dartmouth's Norris Cotton Cancer Center find that unique immune cells, called resident memory T cells, do an outstanding job of preventing melanoma in patients who develop the autoimmune disease, vitiligo.
Researchers document how melanoma tumors form
University of Iowa researchers have documented in continuous, real time how melanoma cells form tumors.
New driver, target in advanced mucosal melanoma
A University of Colorado Cancer Center study published March 15, 2017, in the journal Melanoma Research uses the unique resource of over 600 melanoma samples collected at the university to demonstrate, for the first time, novel mutations involved in mucosal melanoma, paving the way for therapies to treat this overlooked subtype.
NIH study reveals how melanoma spreads
Newly identified genes and genetic pathways in primary melanoma -- a type of skin cancer -- could give researchers new targets for developing new personalized treatments for melanoma, and potentially other cancers.
Melanoma research breakthrough gives hope to treatment
A QUT-driven project has identified the way in which melanoma cells spread, opening up new pathways to treatment via drugs to 'turn off' the invasive gene.
Study examines melanoma incidence, death
A new research letter published online by JAMA Dermatology updates information on trends in melanoma incidence and death in the United States since 2009.
Research providing promising new treatments for melanoma
In a paper published online Nov. 30, 2016, in Melanoma Management, Adam Riker, M.D., Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, including one tested at LSU Health New Orleans that provoked a complete response in a patient with a long history of the disease.
A protein that defines the melanoma blueprint
The latest study of the Melanoma Group at the Spanish National Cancer Research Centre describes the roles of CPEB4; a protein that is crucial for melanoma cell survival.
Nanotechnology supports treatment of malignant melanoma
Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.
Detecting melanoma early, without a biopsy
Colorado State University Professor Jesse Wilson has received a one-year, $30,000 grant from the Colorado Clinical and Translational Sciences Institute to develop a new microscope that can distinguish between benign and malignant pigmented skin lesions, without the need for biopsy.

Related Melanoma Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.